Showing results (1-10 of 304) with videos related to
Sort By:
Pageof 31
The American Journal of Psychiatry|September 1, 1997
Time to clozapine response in a standardized trialR R Conley, W T Carpenter, C A TammingaThe American Journal of Psychiatry|June 1, 1995
Patient response and resource management: another view of clozapine treatment of schizophreniaW T Carpenter, R R Conley, R W Buchanan, et al.The Journal of Clinical Psychiatry|January 1, 1997
The application of neuroimaging techniques to drug developmentC A Tamminga, R R ConleyThe Journal of Nervous and Mental Disease|December 1, 1982
The DSM-III diagnosis of schizophrenic-like illness and the clinical pharmacology of psychosisC A Tamminga, W T CarpenterSchizophrenia Research|March 27, 1999
Sense and nonsense: an essay on schizophrenia research ethicsW T Carpenter, R R ConleySchizophrenia Research|December 11, 1999
Differential olanzapine plasma concentrations by sex in a fixed-dose studyD L Kelly, R R Conley, C A TammingaBiological Psychiatry|October 16, 2001
A comparison of symptom provocation procedures in psychiatry and other areas of medicine: implications for their ethical use in researchM T Avila, R R Conley, W T CarpenterBiological Psychiatry|July 8, 1999
Treatment-resistant schizophrenic patients respond to clozapine after olanzapine non-responseR R Conley, C A Tamminga, D L Kelly, et al.Biological Psychiatry|December 1, 1992
Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatientsB Kirkpatrick, W T Carpenter, K Maeda, et al.Biological Psychiatry|June 1, 1989
Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptationB Kirkpatrick, R W Buchanan, K Maeda, et al.Pageof 31